Cargando…
Management of hot flashes in women with breast cancer
Hormone-suppression therapies are used for the treatment of breast cancer in the adjuvant and metastatic settings alike. However, side effects—including hot flashes—are frequently reported by patients as a cause of therapy discontinuation. This paper presents an overview of hormonal therapies and th...
Autores principales: | Kligman, L., Younus, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826783/ https://www.ncbi.nlm.nih.gov/pubmed/20179808 |
Ejemplares similares
-
Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010) -
Reproductive concerns among young adult women with breast cancer: a systematic review protocol
por: Hu, Li, et al.
Publicado: (2023) -
Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study
por: Ahlstedt Karlsson, Susanne, et al.
Publicado: (2022) -
Perceived needs and health-related quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study
por: Li, Minjie, et al.
Publicado: (2022) -
Leveraging breast cancer screening to promote timely detection, diagnosis and treatment among women in sub-Saharan Africa: a scoping review protocol
por: Yakong, Vida Nyagre, et al.
Publicado: (2022)